000 01596 a2200409 4500
005 20250515193548.0
264 0 _c20100326
008 201003s 0 0 eng d
022 _a1552-5783
024 7 _a10.1167/iovs.09-4009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDutt, Mahasweta
245 0 0 _aTiming of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis.
_h[electronic resource]
260 _bInvestigative ophthalmology & visual science
_cMar 2010
300 _a1439-45 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCell Count
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDexamethasone
_xadministration & dosage
650 0 4 _aEncephalomyelitis, Autoimmune, Experimental
_xpathology
650 0 4 _aFemale
650 0 4 _aFluorescent Dyes
_xmetabolism
650 0 4 _aGlucocorticoids
_xadministration & dosage
650 0 4 _aMethylprednisolone
_xadministration & dosage
650 0 4 _aMice
650 0 4 _aOptic Neuritis
_xdrug therapy
650 0 4 _aRetinal Ganglion Cells
_xdrug effects
650 0 4 _aStilbamidines
_xmetabolism
650 0 4 _aTime Factors
700 1 _aTabuena, Philomela
700 1 _aVentura, Elvira
700 1 _aRostami, Abdolmohamad
700 1 _aShindler, Kenneth S
773 0 _tInvestigative ophthalmology & visual science
_gvol. 51
_gno. 3
_gp. 1439-45
856 4 0 _uhttps://doi.org/10.1167/iovs.09-4009
_zAvailable from publisher's website
999 _c19280797
_d19280797